Company

Company Outline

Company Name

Novacellum,inc
Established

December 2019
Capital

5,500,000 yen
Members

Chairman; Naohide Yamashita (Professor Emeritus, The University of Tokyo, Doctor of Medicine)
Representative; Director Masaki Ohara
Location

7F, Sagamiya Headquarters Building, 6 Ichibancho, Chiyoda-ku, Tokyo 102-0082
Business

Research on diseases using genes and gene products, cells, and tissues, development of therapeutic methods, and sales of the results, etc.

Access

7F, Sagamiya Headquarters Building, 6 Ichibancho, Chiyoda-ku, Tokyo　

3 minutes walk from Exit 5 of Hanzomon Station on the Hanzomon Subway Line

large map

Message

Nova Serum Co., Ltd. aims to develop new treatments to meet the needs of society. Since the clinical application of immune checkpoint inhibitors, immunotherapy for cancer has received a great deal of attention. However, only some patients are effective, and further progress in cancer immunotherapy is desired. In addition, the development of personalized medicine using genomic information is remarkable, and neoantigen immunotherapy by fusion with cancer immunotherapy is also being performed.

We are committed to developing new therapies for our patients. Chairman Naohide Yamashita

Chairman Naohide Yamashita

Chairman Naohide Yamashita
Professor Emeritus, University of Tokyo, Doctor of Medicine

1977
Graduated from the University of Tokyo School of Medicine in 1977
2001-2016
Professor, Institute of Medical Science, University of Tokyo
2006-2010
Director, Institute of Medical Science, University of Tokyo
2019-
Present Chairman of Novacellum inc.

Representative Director Masaki Ohara